Alliancebernstein L.P. Sage Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 61,100 shares of SAGE stock, worth $648,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,100

Previous 61,100 -0.0%

Holding current value

$648,882

Previous $1.32 Million 13.52%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$40.65 - $59.54 $24,390 - $35,724	600 Added 0.99%	61,100 $2.87 Million
Q3 2022 Nov 15, 2022	SELL	$32.28 - $43.27 $2.47 Million - $3.32 Million	-76,662 Reduced 55.89%	60,500 $2.37 Million
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $1.43 Million - $1.98 Million	-52,128 Reduced 27.54%	137,162 $4.43 Million
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $1.88 Million - $2.8 Million	61,235 Added 47.82%	189,290 $6.27 Million
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $1.39 Million - $1.77 Million	37,609 Added 41.58%	128,055 $5.45 Million

Q3 2021 Nov 10, 2021	BUY	$40.26 - $57.37 $2.73 Million - $3.89 Million	67,832 Added 299.96%	90,446 $4.01 Million
Q2 2021 Jul 30, 2021	SELL	$54.88 - $79.29 $47.4 Million - $68.5 Million	-863,302 Reduced 97.45%	22,614 $1.29 Million
Q1 2021 May 06, 2021	BUY	$70.65 - $96.76 $57.3 Million - $78.5 Million	811,600 Added 1092.09%	885,916 $66.3 Million
Q4 2020 Feb 08, 2021	BUY	$58.41 - $89.06 $2.84 Million - $4.34 Million	48,685 Added 189.95%	74,316 $6.43 Million
Q3 2020 Nov 12, 2020	SELL	$41.13 - $62.45 $4,113 - $6,245	-100 Reduced 0.39%	25,631 $1.57 Million
Q2 2020 Aug 13, 2020	SELL	$25.95 - $43.15 $783,949 - $1.3 Million	-30,210 Reduced 54.0%	25,731 $1.07 Million
Q1 2020 May 14, 2020	BUY	$26.15 - $77.24 $653,227 - $1.93 Million	24,980 Added 80.68%	55,941 $1.61 Million
Q4 2019 Feb 18, 2020	SELL	$60.18 - $154.77 $23.1 Million - $59.4 Million	-383,657 Reduced 92.53%	30,961 $2.24 Million
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $1.97 Million - $2.66 Million	-14,025 Reduced 3.27%	414,618 $58.2 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $2.91 Million - $3.37 Million	-18,429 Reduced 4.12%	428,643 $78.5 Million
Q1 2019 May 14, 2019	SELL	$89.33 - $163.65 $2.18 Million - $4 Million	-24,457 Reduced 5.19%	447,072 $71.1 Million
Q4 2018 Feb 13, 2019	BUY	$81.94 - $139.71 $4.69 Million - $8 Million	57,233 Added 13.81%	471,529 $45.2 Million
Q3 2018 Nov 08, 2018	SELL	$138.11 - $169.04 $6.14 Million - $7.51 Million	-44,425 Reduced 9.68%	414,296 $58.5 Million
Q2 2018 Aug 13, 2018	SELL	$140.36 - $175.76 $10.5 Million - $13.2 Million	-74,921 Reduced 14.04%	458,721 $71.8 Million
Q1 2018 May 14, 2018	SELL	$152.15 - $192.33 $7.2 Million - $9.1 Million	-47,340 Reduced 8.15%	533,642 $86 Million
Q4 2017 Feb 13, 2018	SELL	$60.72 - $167.34 $1.41 Million - $3.89 Million	-23,237 Reduced 3.85%	580,982 $95.7 Million
Q3 2017 Nov 13, 2017	BUY	$61.4 - $88.52 $37.1 Million - $53.5 Million	604,219	604,219 $37.6 Million

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $631M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Sage Therapeutics, Inc. Transaction History